Refine by
Sepsis Articles & Analysis
73 news found
Various types include: · Methicillin-resistant Staphylococcus aureus (MRSA) · Methicillin-susceptible Staphylococcus aureus (MSSA) · Vancomycin-intermediate Staphylococcus aureus (VISA) · Vancomycin-resistant Staphylococcus aureus (VRSA) “These infections may include bacteremia or sepsis, pneumonia, endocarditis ...
With a strong focus on unpicking the glycobiology of the innate immune system, the group seeks to advance molecular and cellular understanding of the role of glycoproteins in immune-related disorders including in cancer and inflammation and upon pathogen infections including sepsis, tuberculosis and cystic fibrosis. As a leading provider of biopharmaceutical and proteomics ...
While medical AI has many potential benefits, there are challenges that have not been tackled yet. One of the major challenges is the limited generalizability of many AI algorithms. Applying a medical AI algorithm that is trained in hospital A may give unexpected results when applied in hospital B. Why does this happen? Certain parameters are different between hospitals. If hospital A has Siemens ...
Marking “World Sepsis Day”, The Centre for Drug Research and Development (CDRD) announces the spin-off of a new company, Sepset Biosciences Inc. ...
Mortality from sepsis increases by 8% for every hour that treatment is delayed. Current methods to diagnose sepsis take more than 24 hours, by which time patients are often well on their way towards tissue damage, organ failure, and death. “Sepsis is a global problem and we need a better and faster way of detecting sepsis ...
It is mentioned in the presentation that "Dysregulated interleukin-6 (IL-6) levels underlie several pathological conditions, such as sepsis, progression of cancer, rheumatoid arthritis, and many other conditions. ...
(NASDAQ: AXDX) an in-vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis, today announced the launch of the Accelerate Arc system, comprised of the Arc Module and BC Kit, an automated path to rapid and accurate microbial identification for positive blood cultures. ...
Bluejay’s first product candidate, the Symphony IL-6 Test for sepsis triage, is designed to provide accurate, reliable results in approximately 20 minutes from ‘sample-to-result’ to help medical professionals make earlier and better triage/treatment ...
” The impact of the lack of new antibiotics is already being felt across the world, with 30% of new-borns with sepsis dying due to bacterial infections resistant to first-line antibiotics[i]. ...
Creative Proteomics Cytokine recently launched the Mouse Cytokine Assay with high sensitivity to support research in immune responses, inflammatory diseases, allergies, sepsis, and cancer. Cytokines play an important role in physiological and pathological processes such as immune cell differentiation and subset development, immune regulation, inflammatory response, and tumor ...
Bluejay’s first product candidate, an IL-6 Test for sepsis triage, is designed to provide accurate, reliable results in approximately 20 minutes from ‘sample-to-result’ to help medical professionals make earlier and better triage/treatment ...
Results demonstrated a significant correlation between the diagnosis of sepsis and an elevated SeptiScore®. From eight patients diagnosed with either septic shock or sepsis, six had elevated scores and two had intermediate-elevated scores. ...
Robert Hancock and Olga Peña—who lost her father to sepsis—may have found a way to diagnose the deadliest syndrome you’ve never heard of. ...
The ambition for IBP-9414 is to become the world’s first approved probiotical drug with the goal to prevent life threatening diseases in premature infants including NEC and sepsis by promoting healthy stomach-and bowel development in premature infants. ...
In addition, TNF can inhibit viral replication and respond to sepsis by inducing Interleukins 1 and 6. It is one of the earliest cytokines produced and may have both a direct effect on cells and tissues and an indirect effect on inducing cell types to produce other cytokines. ...
With the trajectory of antimicrobial resistance and sepsis, labs need access to a fast, scalable Rapid AST system with broad antibiotic panels. ...
The ambition for IBP-9414 is to become the world’s first approved probiotical drug with the goal to prevent life threatening diseases in premature infants including NEC and sepsis by promoting sound stomach-and bowel development in premature infants. ...
Bluejay’s first product candidate, an IL-6 Test for sepsis triage, is designed to provide accurate, reliable results in approximately 24 minutes from ‘sample-to-result’ to help medical professionals make earlier and better triage/treatment ...
” Data from this study builds on previously published studies that have shown that Cytovale’s IntelliSep test quickly and clearly distinguished sepsis risk in a high-acuity population and helped to identify patients with infections severe enough to cause morbidity and mortality1. ...
Cytovale, a medical diagnostics company focused on providing rapid and insightful tools to improve early detection of fast-moving and immune-mediated diseases, has received additional funding from Biomedical Research and Development Authority (BARDA) to help advance the company’s 10-minute IntelliSep sepsis risk stratification test towards commercial launch. This latest ...